Skip to main content
S&P 5007,807.20-0.06%DOW51,850.31+0.38%NASDAQ27,245.90-0.44%BTC$82,773.00-0.98%ETH$2,519.97-0.56%GOLD$4,192.50-0.56%OIL$93.33+1.61%
Smart Investors Daily
SID Premium
CL

NASDAQ · CLOV

Clover Health Investments, Corp.

Healthcare · Medical - Healthcare Plans

$4.79

Down-$0.01 (-0.21%)

Updated Oct 12, 2026, 8:02 PM

SID Score

6.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.42B
P/E ratio
-24.25
Dividend yield
0.00%
52-week range
$1.58 – $5.59
Volume
10.55M
Avg. volume
8.79M

Price performance · CLOV

CLOV price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

CLOV closed at $4.79 after 20 trading sessions, down 6.08% for the selected period.

Last close
$4.79
Period change
-6.08%
Period low
$4.23
Period high
$5.10
Daily close
View OHLC price history
CLOV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$5.17$5.21$4.635$4.7910.55M
Oct 8, 2026$4.50$4.60$4.44$4.585.52M
Oct 7, 2026$4.55$4.75$4.5276$4.567.42M
Oct 6, 2026$4.68$4.69$4.58$4.603.35M
Oct 5, 2026$4.39$4.71$4.35$4.684.88M
Oct 2, 2026$4.27$4.41$4.225$4.383.86M
Oct 1, 2026$4.25$4.31$4.11$4.233.58M
Sep 30, 2026$4.27$4.41$4.215$4.313.34M
Sep 29, 2026$4.33$4.35$4.265$4.3252.66M
Sep 28, 2026$4.45$4.525$4.27$4.333.33M
Sep 25, 2026$4.525$4.67$4.47$4.493.61M
Sep 24, 2026$4.59$4.6468$4.43$4.513.2M
Sep 23, 2026$4.66$4.66$4.47$4.573.34M
Sep 22, 2026$4.61$4.69$4.52$4.674.52M
Sep 21, 2026$4.53$4.57$4.45$4.542.84M
Sep 18, 2026$4.50$4.515$4.36$4.466.17M
Sep 17, 2026$4.56$4.775$4.505$4.543.69M
Sep 16, 2026$4.73$4.75$4.55$4.563.84M
Sep 15, 2026$5.06$5.0964$4.59$4.669.66M
Sep 14, 2026$4.82$5.185$4.82$5.105.49M

Latest CLOV news

The latest Smart Investors Daily articles mentioning CLOV.

Stock researchCompany · Overview

CLOV research

Overview

Company profile and research snapshot.

Company profile

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.00
Implied upside
—
Analysts
—
CLOV recent ratings
DateFirmRatingTarget
Aug 6, 2026UBSNeutral—
Jul 21, 2026Canaccord GenuityBuy—
Jun 11, 2026UBSNeutral—
Jun 4, 2026Canaccord GenuityBuy—
Mar 20, 2026Canaccord GenuityBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 4, 2026

Clover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap?

Clover Health Investments (CLOV) just rolled out its 2027 Medicare Advantage lineup, highlighting high-choice PPO plans, $0 to low premiums, and a tech-supported care model through its Clover Assistant platform. Clover Health Investments has seen strong positive momentum this year, with an 81.74% year to date share price return. The 1 year total shareholder return of 69.11% and the very large 3 year total shareholder return of about 4x suggest that longer term holders have already experienced...

Yahoo · Oct 2, 2026

3 Great Healthcare Stocks To Own In October 2026

Global bond markets have just steadied after a sharp sell off that pushed US borrowing costs to levels last seen in 2002, which keeps reliable cash generation and robust finances firmly in focus. That backdrop puts financially solid healthcare leaders, from drug developers to equipment makers, on many watchlists. This article walks through three stand out stocks from a curated healthcare shortlist that meet those quality filters. The three healthcare stocks highlighted next are only a...

Yahoo · Oct 1, 2026

Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value

Clover’s portfolio combines high-choice PPO access and meaningful member benefits with a Clover Assistant-powered care modelWILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its 2027 Medicare Advantage (MA) plan offerings, with a continued focus on PPO choice, affordable

Yahoo · Sep 24, 2026

UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors

WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to the Company’s Board of Directors, effective immediately. The appointments bring together two accomplished leaders whose complementary experience spans public service, Medicare Advantage, clinical practice, healthcare policy, and b

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By